These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5238591)

  • 1. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane.
    Connell JT
    J Allergy; 1968 Mar; 41(3):123-39. PubMed ID: 5238591
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal and bronchial histamine responsiveness in pollen-exposed patients with seasonal rhinitis.
    Ehnhage A; Kölbeck KG; Mossberg B; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):191-9. PubMed ID: 12037386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal Local Allergic Rhinitis in Areas With High Concentrations of Grass Pollen.
    Blanca-Lopez N; Campo P; Salas M; García Rodríguez C; Palomares F; Blanca M; Canto G; Feo Brito F; Rondon C
    J Investig Allergol Clin Immunol; 2016; 26(2):83-91. PubMed ID: 27164623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response in rabbits following intranasal and parenteral administration of birch pollen.
    Belin L; Strannegård O
    Int Arch Allergy Appl Immunol; 1971; 41(5):655-69. PubMed ID: 5005895
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
    Horak F; Stübner P; Zieglmeyer R; Harris AG
    Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber.
    Okuma Y; Okamoto Y; Yonekura S; Iinuma T; Sakurai T; Hamasaki S; Ohki Y; Yamamoto H; Sakurai D
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):150-7. PubMed ID: 27263086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal immunotherapy in weed-induced allergic rhinitis.
    Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE antibodies in nasal secretions of ragweed-allergic subjects.
    Tse KS; Wicher K; Arbesman CE
    J Allergy; 1970 Dec; 46(6):352-7. PubMed ID: 4099754
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
    Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
    J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo.
    Gilles-Stein S; Beck I; Chaker A; Bas M; McIntyre M; Cifuentes L; Petersen A; Gutermuth J; Schmidt-Weber C; Behrendt H; Traidl-Hoffmann C
    Clin Exp Allergy; 2016 Oct; 46(10):1355-65. PubMed ID: 27061126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit.
    North ML; Jones MJ; MacIsaac JL; Morin AM; Steacy LM; Gregor A; Kobor MS; Ellis AK
    Allergy; 2018 Jan; 73(1):196-205. PubMed ID: 28755526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal secretion eosinophilia in children with grass pollen hay fever.
    Murray AB
    Can Med Assoc J; 1971 Apr; 104(7):599-600. PubMed ID: 5550549
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of antihistamine on up-regulation of histamine H1 receptor mRNA in the nasal mucosa of patients with pollinosis induced by controlled cedar pollen challenge in an environmental exposure unit.
    Kitamura Y; Nakagawa H; Fujii T; Sakoda T; Enomoto T; Mizuguchi H; Fukui H; Takeda N
    J Pharmacol Sci; 2015 Nov; 129(3):183-7. PubMed ID: 26598006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of rhinomanometry in the diagnosis and therapy of perennial allergic rhinitis].
    Gyeney L; Hajós M
    Orv Hetil; 1976 Oct; 117(40):2424-6. PubMed ID: 967453
    [No Abstract]   [Full Text] [Related]  

  • 20. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.